Compounds > pioglitazone
Page last updated: 2024-08-16

pioglitazone and everolimus

pioglitazone has been researched along with everolimus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abete, C; Dessì, S; Fossarello, M; Galantuomo, MS; Mulas, MF; Peiretti, E1
Abete, C; Dessì, S; Fossarello, M; Mulas, C; Norfo, C; Peiretti, E; Putzolu, M1
Abete, C; Cannas, MD; Dessì, S; La Colla, P; Laconi, S; Mulas, C; Norfo, C; Orrù, CD; Pani, A; Putzolu, M; Vascellari, S1

Reviews

1 review(s) available for pioglitazone and everolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for pioglitazone and everolimus

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics.
    Experimental eye research, 2006, Volume: 83, Issue:3

    Topics: Aged; Case-Control Studies; Cell Proliferation; Cell Separation; Cell Survival; Cells, Cultured; Cholesterol; Conjunctiva; Esters; Everolimus; Female; Fibroblasts; Humans; Lipid Metabolism; Male; Middle Aged; Pioglitazone; Pterygium; Sirolimus; Thiazolidinediones

2006
Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:8

    Topics: Aged; Amides; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caveolin 1; Cell Division; Cells, Cultured; Cholesterol; Cholesterol Esters; Enzyme Inhibitors; Everolimus; Female; Fibroblasts; Homeostasis; Humans; Hypoglycemic Agents; Immunosuppressive Agents; In Vitro Techniques; Male; Middle Aged; Organosilicon Compounds; Pioglitazone; Progesterone; Pterygium; RNA, Messenger; Sirolimus; Sterol O-Acyltransferase; Thiazolidinediones

2007
Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cholesterol; Cholesterol Esters; Dose-Response Relationship, Drug; Esterification; Everolimus; Fibroblasts; Genotype; Lymphocytes; Mice; Neuroblastoma; Pioglitazone; Prions; Scrapie; Sheep; Sheep Diseases; Sirolimus; Thiazolidinediones

2007